Targeted disruption ofTraf5gene causes defects in CD40- and CD27-mediated lymphocyte activation
Mice, Knockout
TNF Receptor-Associated Factor 5
Membrane Glycoproteins
CD40 Ligand
JNK Mitogen-Activated Protein Kinases
NF-kappa B
Proteins
Lymphocyte Activation
Tumor Necrosis Factor Receptor Superfamily, Member 7
Enzyme Activation
Mice
03 medical and health sciences
0302 clinical medicine
Calcium-Calmodulin-Dependent Protein Kinases
Animals
CD40 Antigens
Mitogen-Activated Protein Kinases
DOI:
10.1073/pnas.96.17.9803
Publication Date:
2002-07-26T14:41:48Z
AUTHORS (17)
ABSTRACT
TRAF5 [tumor necrosis factor (TNF) receptor-associated factor 5] is implicated in NF-κB and c-Jun NH2-terminal kinase/stress-activated protein kinase activation by members of the TNF receptor superfamily, including CD27, CD30, CD40, and lymphotoxin-β receptor. To investigate the functional role of TRAF5in vivo, we generated TRAF5-deficient mice by gene targeting. Activation of either NF-κB or c-Jun NH2-terminal kinase/stress-activated protein kinase by tumor necrosis factor, CD27, and CD40 was not abrogated intraf5−/−mice. However,traf5−/−B cells showed defects in proliferation and up-regulation of various surface molecules, including CD23, CD54, CD80, CD86, and Fas in response to CD40 stimulation. Moreover,in vitroIg production oftraf5−/−B cells stimulated with anti-CD40 plus IL-4 was reduced substantially. CD27-mediated costimulatory signal also was impaired intraf5−/−T cells. Collectively, these results demonstrate that TRAF5 is involved in CD40- and CD27-mediated signaling.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (34)
CITATIONS (148)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....